Onco-Innovations Revenue

Onco-Innovations had revenue of 154.67K CAD in the twelve months ending January 31, 2026. In the fiscal year ending April 30, 2025, Onco-Innovations had annual revenue of 65.29K.

Revenue (ttm)

154.67K

Revenue Growth

n/a

P/S Ratio

442.89

Revenue / Employee

n/a

Employees

n/a

Market Cap

68.50M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2025	65.29K	-	-
Apr 30, 2024	-	-	-
Apr 30, 2023	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Onco-Innovations News

11 days ago - Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program - Accesswire
15 days ago - Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate - Accesswire
18 days ago - Onco-Innovations Announces Initiation of Research Collaboration within PROmAI - Accesswire
22 days ago - Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology - Accesswire
25 days ago - Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation - Accesswire
4 weeks ago - Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies - Accesswire
4 weeks ago - Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program - Accesswire
5 weeks ago - Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies - Accesswire

More News